tak 779 has been researched along with fenofibrate in 1 studies
Studies (tak 779) | Trials (tak 779) | Recent Studies (post-2010) (tak 779) | Studies (fenofibrate) | Trials (fenofibrate) | Recent Studies (post-2010) (fenofibrate) |
---|---|---|---|---|---|
118 | 1 | 35 | 3,058 | 529 | 1,354 |
Protein | Taxonomy | tak 779 (IC50) | fenofibrate (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 2.371 | |
Adenosine receptor A3 | Homo sapiens (human) | 5.701 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 5.701 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 2.118 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 2.371 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 5.701 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 8.633 | |
Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | 1 | |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 5.1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Fenaux, M; Halcomb, RL; Jones, CT; Romero, FA; Xu, Y | 1 |
1 review(s) available for tak 779 and fenofibrate
Article | Year |
---|---|
The Race to Bash NASH: Emerging Targets and Drug Development in a Complex Liver Disease.
Topics: Animals; Anticholesteremic Agents; Drug Delivery Systems; Drug Development; Humans; Hypoglycemic Agents; Lipid Metabolism; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Obesity; PPAR gamma; Protein Structure, Tertiary | 2020 |